Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0761
F

Improper Medication Labeling and Storage

Woodland, California Survey Completed on 07-30-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

Surveyors observed that the facility failed to ensure medications were properly labeled and stored according to facility policies and accepted professional standards. Specifically, five loose pills were found in a medication cart, which were confirmed by a licensed nurse, who acknowledged that staff would not be able to identify the medications. Both the consultant pharmacist and the director of nursing confirmed that loose pills should not be present in medication carts due to safety concerns and the need to keep carts clean. Additionally, opened Polymyxin B-tmp eye drops, Incruse Ellipta inhaler, and Symbicort inhaler were found without opened date labels, contrary to facility policy and manufacturer instructions, which require labeling with the date opened to ensure timely disposal. A used Latanoprost eye drop with an opened date exceeding 28 days was also found in the medication cart, despite the requirement to discard after 28 days. Both the consultant pharmacist and the director of nursing confirmed that these medications should have been labeled and discarded as per protocol.

An unhandled error has occurred. Reload 🗙